SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2780966665> ?p ?o ?g. }

Showing items 1 to 100 of ±134 with 100 items per page.

W2780966665 endingPage "1219" @default.
W2780966665 startingPage "1207" @default.
W2780966665 abstract "The blockade of immune checkpoints by anti-receptor and/or anti-ligand mAb is one of the most promising approaches to cancer immunotherapy. The interaction between Ig-like transcript 3 (ILT3), a marker of tolerogenic dendritic cells, also known as LILRB4/LIR5/CD85k, and its still unidentified ligand on the surface of activated human T cells is potentially important for immune checkpoint blockade. To identify the ILT3 ligand, we generated mAb by immunizing mice with Jurkat acute T cell leukemia, which binds ILT3.Fc to its membrane. Flow cytometry, mass spectrometry, and Biacore studies demonstrated that the ILT3 ligand is a CD166/activated leukocyte cell adhesion molecule. Knockdown of CD166 in primary human T cells by nucleofection abolished the capacity of ILT3.Fc to inhibit CD4+ Th cell proliferation and to induce the generation of CD8+CD28- T suppressor cells. CD166 displays strong heterophilic interaction with CD6 and weaker homophilic CD166-CD166 cell adhesion interaction. ILT3.Fc inhibited the growth of CD166+ tumor cell lines (TCL) derived from lymphoid malignancies in vitro and in vivo. CRISPR-Cas9-based knockout of CD166 from TCL abrogated ILT3.Fc binding and its tumor-inhibitory effect. The mechanism underlying the effect of ILT3.Fc on tumor cell growth involves inhibition of the p70S6K signaling pathway. Blockade of CD166 by ILT3.Fc inhibited progression of human TCL in NOD.Cg-Prkdc Il-2rg/SzJ mice, suggesting its potential immunotherapeutic value." @default.
W2780966665 created "2018-01-05" @default.
W2780966665 creator A5002398433 @default.
W2780966665 creator A5004877715 @default.
W2780966665 creator A5017598017 @default.
W2780966665 creator A5026267355 @default.
W2780966665 creator A5026609346 @default.
W2780966665 creator A5045351289 @default.
W2780966665 creator A5061035980 @default.
W2780966665 creator A5063324263 @default.
W2780966665 creator A5090563981 @default.
W2780966665 date "2017-12-20" @default.
W2780966665 modified "2023-10-16" @default.
W2780966665 title "ILT3.Fc–CD166 Interaction Induces Inactivation of p70 S6 Kinase and Inhibits Tumor Cell Growth" @default.
W2780966665 cites W1484140899 @default.
W2780966665 cites W1534876192 @default.
W2780966665 cites W1535350845 @default.
W2780966665 cites W1570842557 @default.
W2780966665 cites W1649473267 @default.
W2780966665 cites W1822745879 @default.
W2780966665 cites W1943621156 @default.
W2780966665 cites W1964035033 @default.
W2780966665 cites W1965350162 @default.
W2780966665 cites W1973614663 @default.
W2780966665 cites W1973987878 @default.
W2780966665 cites W1977709885 @default.
W2780966665 cites W1982023788 @default.
W2780966665 cites W1985745207 @default.
W2780966665 cites W1986060457 @default.
W2780966665 cites W1991551000 @default.
W2780966665 cites W2002031023 @default.
W2780966665 cites W2002066339 @default.
W2780966665 cites W2003060606 @default.
W2780966665 cites W2003337757 @default.
W2780966665 cites W2003876192 @default.
W2780966665 cites W2005115971 @default.
W2780966665 cites W2022022565 @default.
W2780966665 cites W2028376975 @default.
W2780966665 cites W2032166347 @default.
W2780966665 cites W2035469701 @default.
W2780966665 cites W2038564346 @default.
W2780966665 cites W2041926656 @default.
W2780966665 cites W2044590966 @default.
W2780966665 cites W2052806541 @default.
W2780966665 cites W2055410070 @default.
W2780966665 cites W2064815984 @default.
W2780966665 cites W2066671159 @default.
W2780966665 cites W2071268727 @default.
W2780966665 cites W2094034290 @default.
W2780966665 cites W2097065948 @default.
W2780966665 cites W2098882192 @default.
W2780966665 cites W2110443482 @default.
W2780966665 cites W2113702155 @default.
W2780966665 cites W2117937907 @default.
W2780966665 cites W2127387126 @default.
W2780966665 cites W2128695497 @default.
W2780966665 cites W2131309893 @default.
W2780966665 cites W2143407286 @default.
W2780966665 cites W2144899382 @default.
W2780966665 cites W2145809457 @default.
W2780966665 cites W2157569416 @default.
W2780966665 cites W2161409973 @default.
W2780966665 cites W2195967565 @default.
W2780966665 cites W2394893668 @default.
W2780966665 cites W273285908 @default.
W2780966665 cites W3099289621 @default.
W2780966665 cites W4247832335 @default.
W2780966665 doi "https://doi.org/10.4049/jimmunol.1700553" @default.
W2780966665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29263213" @default.
W2780966665 hasPublicationYear "2017" @default.
W2780966665 type Work @default.
W2780966665 sameAs 2780966665 @default.
W2780966665 citedByCount "29" @default.
W2780966665 countsByYear W27809666652018 @default.
W2780966665 countsByYear W27809666652019 @default.
W2780966665 countsByYear W27809666652020 @default.
W2780966665 countsByYear W27809666652021 @default.
W2780966665 countsByYear W27809666652022 @default.
W2780966665 countsByYear W27809666652023 @default.
W2780966665 crossrefType "journal-article" @default.
W2780966665 hasAuthorship W2780966665A5002398433 @default.
W2780966665 hasAuthorship W2780966665A5004877715 @default.
W2780966665 hasAuthorship W2780966665A5017598017 @default.
W2780966665 hasAuthorship W2780966665A5026267355 @default.
W2780966665 hasAuthorship W2780966665A5026609346 @default.
W2780966665 hasAuthorship W2780966665A5045351289 @default.
W2780966665 hasAuthorship W2780966665A5061035980 @default.
W2780966665 hasAuthorship W2780966665A5063324263 @default.
W2780966665 hasAuthorship W2780966665A5090563981 @default.
W2780966665 hasBestOaLocation W27809666651 @default.
W2780966665 hasConcept C153911025 @default.
W2780966665 hasConcept C179464577 @default.
W2780966665 hasConcept C185592680 @default.
W2780966665 hasConcept C203014093 @default.
W2780966665 hasConcept C2776090121 @default.
W2780966665 hasConcept C2777701055 @default.
W2780966665 hasConcept C2780674031 @default.
W2780966665 hasConcept C502942594 @default.